Actionable news
0
All posts from Actionable news
Actionable news in BMRN: BioMarin Pharmaceutical Inc.,

BioMarin Pharmaceutical Inc. releases salary data. CEO sees compensation rise 25%

BioMarin Pharmaceutical Inc. just filed its annual proxy statement, which details the salary information of its key executives. In 2015, the company's CEO made 13,636,550.

The table is included below:

Name and Principal Position

Year

Salary (1)

Bonus (2)

Stock

Awards (3)

Option

Awards (4)

Non-Equity

Incentive Plan

Compensation (5)

All Other

Compensation (6)

Total

Jean-Jacques Bienaimé

2015

$

973,461

$

6,436,584

$

4,768,445

$

1,408,550

$

49,510

$

13,636,550

Chief Executive Officer

2014

916,030

3,211,790

5,867,520

864,875

38,177

10,898,392

2013

868,796

2,563,218

6,850,935

1,054,030

27,059

11,364,038

Daniel Spiegelman

2015

505,192

1,712,088

1,259,291

362,546

22,941

3,862,058

Executive Vice President,

2014

480,576

870,780

1,588,224

226,738

17,413

3,183,731

Chief Financial Officer

2013

457,769

895,092

2,392,390

277,200

6,838

4,029,289

Jeff Ajer

2015

445,193

1,712,088

1,259,291

323,606

16,500

3,756,678

Executive Vice President,

2014

417,674

719,340

1,311,744

212,500

16,043

2,677,301

Chief Commercial Officer

2013

382,688

569,604

1,522,430

185,712

7,563

2,667,997

Robert A. Baffi, Ph.D.

2015

449,231

1,712,088

1,259,291

323,448

19,819

3,763,877

Executive Vice President,

2014

417,875

795,060

1,449,984

198,688

18,338

2,879,945

Technical Operations

2013

384,391

30,000

(7)

813,720

2,174,900

232,766

9,664

3,645,441

Henry J. Fuchs, M.D.

2015

563,269

2,178,036

1,607,045

405,199

21,738

4,775,287

Executive Vice President &

2014

528,235

984,360

1,794,048

250,113

18,338

3,575,094

Chief Medical Officer

2013

494,383

137,500

(8)

1,057,836

2,827,370

299,895

8,488

4,825,472

The above information was disclosed in a filing to the SEC. To see the filing, click here.

To receive a free e-mail notification whenever BioMarin Pharmaceutical Inc. makes a similar move, sign up!

Other recent filings from the company include the following:

BioMarin Pharmaceutical Inc.'s Chief Executive Officer just picked up 3,000 shares - April 7, 2016